Variation in DNA repair is a factor in cancer susceptibility: A paradigm for the promises and perils of individual and population risk estimation?

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 400, Issue 1-2, 1998, Pages 15-24

  Mohrenweiser, Harvey W ^a   Jones, Irene M ^a  

^a LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

Cancer susceptibility; DNA repair; Genetic variation; Risk estimation

Indexed keywords

CARCINOGEN; DNA;

AMINO ACID SUBSTITUTION; ARTICLE; BASE MISPAIRING; CANCER SUSCEPTIBILITY; COLON CANCER; DNA REPAIR; DNA SEQUENCE; EXCISION REPAIR; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; NONHUMAN; POPULATION RISK; PRIORITY JOURNAL; RISK ASSESSMENT; XERODERMA PIGMENTOSUM;

ANIMALS; DISEASE SUSCEPTIBILITY; DNA REPAIR; HUMANS; NEOPLASMS; ONCOGENES; RISK ASSESSMENT; VARIATION (GENETICS);

EID: 0032565543     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00059-1     Document Type: Article

References (72)

1. [1] K.W. Kinzler, M.C. Nilbert, L.K. Su, B. Vogelstein, T.M. Bryan, D.B. Levy, K.J. Smith, A.C. Preisinger, P. Hedge, D. McKechnie et al., Identification of FAP locus genes from chromosome 5q21, Science 253 (1991) 661-665.
2. [2] M.B. Kastan, O. Onyekwere, D. Sidransky, B. Vogelstein, R.W. Craig, Participation of p53 protein in the cellular response to DNA damage, Cancer Res. 51 (1991) 6304-6311.
3. [3] F.P. Li, J.F. Fraumeni Jr., J.J. Mulvihill, W.A. Blattner, M.G. Dreyfus, M.A. Tucker, R.W. Miller, A cancer family syndrome in twenty-four kindreds, Cancer Res. 48 (1988) 5358-5362.
4. [4] C.I. Szabo, M.C. King, Population genetics of BRCA1 and BRCA2, Am. J. Hum. Genet. 60 (1997) 1013-1020.
5. [5] H.T. Lynch, J.N. Marcus, P. Watson, T. Conway, M.L. Fitzsimmons, J.F. Lynch, Genetic epidemiology of breast cancer, in: H.T. Lynch, T. Hirayama (Eds.), Genetic Epidemiology of Cancer, CRC Press, Boca Raton, FL, 1989, pp. 289-332.
6. [6] R.D. Kolodner, Mismatch repair: mechanisms and relationship to cancer susceptibility, Trends Biochem. Sci. 20 (1995) 397-401.
7. [7] M.J. Renan, Is there a lung-cancer susceptibility gene?, Int. J. Cancer 74 (1997) 359-361.
8. [8] R. Talamini, S. Franceschi, A. Favero, E. Negri, F. Parazzini, C. La Vecchia, Selected medical conditions and risk of breast cancer, Br. J. Cancer 75 (1997) 1699-1703.
9. [9] D.C. Whiteman, P. Valery, W. McWhirter, A.C. Green, Risk factors for childhood melanoma in Queensland, Australia, Int. J. Cancer 70 (1997) 26-31.
10. [10] D.A. Pierce, Y. Shimizu, D.L. Preston, M. Vaeth, K. Mabuchi, Studies of the mortality of atomic bomb survivors: Report 12, Part 1. Cancer: 1950-1990, Radiat. Res. 146 (1996) 1-27.
11. [11] J.L. Kelsey, Breast cancer epidemiology: summary and future directions, Epidemiol. Rev. 15 (1993) 256-263.
12. [12] M.R. Spitz, M.L. Bondy, Genetic susceptibility to cancer, Cancer 72 (1993) 991-995.
13. [13] T.A. Sellers, J.D. Potter, J.E. Bailey-Wilson, S.S. Rich, H. Rothschild, R.C. Elston, Lung cancer detection and prevention: evidence for an interaction between smoking and genetic predisposition, Cancer Res. 52 (1992) 2694s-2697s.
14. [14] P.G. Shields, Pharmacogenetics: detecting sensitive populations, Environ. Health Perspect. 11 (1994) 81-87.
15. [15] K.A. McGlynn, E.A. Rosvold, E.D. Lustbader, Y. Hu, M.L. Clapper, T. Zhou, C.P. Wild, X.L. Xia, A. Baffoe-Bonnie, D. Ofori-Adjei et al., Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1, Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 2384-2387.
16. [16] H. Raunio, K. Husgafvel-Pursiainen, S. Anttila, E. Hietanen, A. Hirvonen, O. Pelkonen, Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility - a review, Gene 159 (1995) 113-121.
17. [17] F.J. Gonzalez, Genetic polymorphism and cancer susceptibility: fourteenth Sapporo Cancer Seminar, Cancer Res. 55 (1995) 710-715.
18. [18] T. Kitagawa, The 1st UICC symposium on the molecular epidemiology of cancer. Union Internationale Contre le Cancer, Int. J. Cancer 71 (1997) 712-714.
19. [19] S. Benhamou, C. Bouchardy, C. Paoletti, P. Dayer, Effects of CYP2D6 activity and tobacco on larynx cancer risk, Cancer Epidemiol. Biomarkers Prev. 5 (1996) 683-686.
20. [20] X. Xu, K.T. Kelsey, J.K. Wiencke, J.C. Wain, D.C. Christiani, Cytochrome P450 CYP1A1 Msp1 polymorphism and lung cancer susceptibility, Cancer Epidemiol. Biomarkers Prev. 5 (1996) 687-692.
21. [21] N. Ishibe, J.K. Wienke, Z.-f. Zuo, A. McMillan, M. Spitz, K.T. Kelsey, Susceptibility to lung cancer in light smokers associated with Cyp1A1 polymorphisms in Mexican- and African-Americans, Cancer Epidemiol. Biomarkers Prev. 6 (1997) 1075-1080.
22. [22] P. Vineis, Molecular epidemiology: low-dose carcinogens and genetic susceptibility, Int. J. Cancer 71 (1997) 1-3.
23. [23] J. Brockmoller, I. Cascorbi, R. Kerb, I. Roots, Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase and cytochrome P450 enzymes as modulators of bladder cancer risk, Cancer Res. 56 (1996) 3915-3925.
24. [24] A.T. Natarajan, J.J. Boei, F. Darroudi, P.C. Van Diemen, F. Dulout, M.P. Hande, A.T. Ramalho, Current cytogenetic methods for detecting exposure and effects of mutagens and carcinogens, Environ. Health Perspect. 3 (1996) 445-448.
25. [25] J.D. Tucker, Molecular cytogenetic analysis of DNA lesions using FISH technology, Mutation Res. 400 (1998) .
26. [26] R.J. Albertini, Biomarkers as tools to enhance public health, Mutation Res. 400 (1998) .
27. [27] R.G. Langlois, W.L. Bigbee, R.H. Jensen, Measurements of the frequency of human erythrocytes with gene expression loss phenotypes at the glycophorin A locus, Hum. Genet. 74 (1986) 353-362.
28. [28] N.P. Verwoerd, L.F. Bernini, J. Bonnet, H.J. Tanke, A.T. Natarajan, et al., Somatic cell mutations in humans detected by image analysis of immunofluorescently stained erythrocytes, in: G. Burger, J.S. Ploem, K. Goerttler (Eds.), Clinical Cytometry and Histometry, Academic Press, San Diego, 1987, pp. 465-469.
29. [29] J. Cole, T.R. Skopek, International Commission for Protection Against Environmental Mutagens and Carcinogens. Working paper no. 3. Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo, Mutation Res. 304 (1994) 33-105.
30. [30] I.M. Jones, D.H. Moore, C.B. Thomas, C.L. Thompson, C.L. Strout, K. Burkhart-Schultz, Factors affecting HPRT mutant frequency in T-lymphocytes of smokers and nonsmokers, Cancer Epidemiol. Biomarkers Prev. 2 (1993) 249-260.
31. [31] M.J. Ramsey, D.H. Moore II, J.F. Briner, D.A. Lee, L.A. Olsen, J.R. Senft, J.D. Tucker, The effects of age and lifestyle factors on the accumulation of cytogenetic damage as measured by chromosome painting, Mutation Res. 338 (1995) 95-106.
32. [32] J.A. Nicklas, T.C. Hunter, J.P. O'Neill, R.J. Albertini, Molecular analyses of in vivo hprt mutations in human T-lymphocytes: III. Longitudinal study of hprt gene structural alterations and T-cell clonal origins, Mutation Res. 215 (1989) 147-160.
33. [33] W.L. Bigbee, J.C. Fuscoe, A.G. Gorvad, K. Harrington-Brock, I.M. Jones, D.H. Moore II, M.M. Moore, C.L. Strout, C.B. Thomas, S.G. Grant, Human in vivo somatic mutation measured at two loci: individuals with stably elevated erythrocyte glycophorin A (GPA) variant frequencies exhibit normal T-lymphocyte hprt mutant frequencies, Mutation Res. (1997) in press.
34. [34] T.J. Cheng, D.C. Christiani, H.L. Liber, J.C. Wain, X. Xu, J.K. Wiencke, K.T. Kelsey, Mutant frequency at the hprt locus in human lymphocytes in a case-control study of lung cancer, Mutation Res. 332 (1995) 109-118.
35. [35] B. Lambert, T. Bastlova, A.M. Osterholm, S.M. Hou, Analysis of mutation at the hprt locus in human T lymphocytes, Toxicol. Lett. 83 (1995) 323-333.
36. [36] R.G. Langlois, A.M. Lockhart, M.A. Watson, C.L. Thompson, D.A. Bell, Evidence that GSTT1 affects the induction of glycophorin A variant cells in smokers, Environ. Mol. Mutagen. 27 (1996) 39, Suppl. 27.
37. [37] L. Hagmar, A. Brogger, I.L. Hansteen, S. Heim, B. Hogstedt, L. Knudsen, B. Lambert, K. Linnainmaa, F. Mitelman, I. Nordenson et al., Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage, Cancer Res. 54 (1994) 2919-2922.
38. [38] M. Radman, I. Matic, J.A. Halliday, F. Taddei, Editing DNA replication and recombination by mismatch repair: from bacterial genetics to mechanisms of predisposition to cancer in humans, Philos. Trans. R. Soc. London Ser. B 347 (1995) 97-103.
39. [39] V.A. Bohr, DNA repair fine structure and its relations to genomic instability, Carcinogenesis 16 (1995) 2885-2892.
40. [40] L. Ma, J.H. Hoeijmakers, A.J. van der Eb, Mammalian nucleotide excision repair, Biochim. Biophys. Acta 1242 (1995) 137-163.
41. [41] T.D. Tlsty, A. Briot, A. Gualberto, I. Hall, S. Hess, M. Hixon, D. Kuppuswamy, S. Romanov, M. Sage, A. White, Genomic instability and cancer, Mutation Res. 337 (1995) 1-7.
42. [42] J.E. Cleaver, K.H. Kraemer, Xeroderma pigmentosum and Cockayne syndrome, in: C.R. Scriver, A.L. Beudet, W.S. Sly, D. Valle (Eds.), The Metabolic and Molecular Basis of Inherited Disease, McGraw-Hill, New York, 1995, pp. 4393-4419.
43. [43] G. Chu, L. Mayne, Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy: do the genes explain the diseases?, Trends Genet. 12 (1996) 187-192.
44. [44] K.W. Caldecott, S. Aoufouchi, P. Johnson, S. Shall, XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro, Nucleic Acids Res. 24 (1996) 4387-4394.
45. [45] Y. Kubota, R.A. Nash, A. Klungland, P. Schar, D.E. Barnes, T. Lindahl, Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein, EMBO J. 15 (1996) 6662-6670.
46. [46] D.M. Wilson III, L.H. Thompson, Life without DNA repair, Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 12754-12757.
47. [47] M.L. Michaels, J.H. Miller, The GO system protects organisms from the mutagenic effect of the spontaneous lesion 8-hydroxyguanine (7,8-dihydro-8-oxoguanine), J. Bacteriol. 174 (1992) 6321-6325.
48. [48] L.A. Loeb, B.D. Preston, Mutagenesis by apurinic / apyrimidinic sites, Annu. Rev. Genet. 20 (1986) 201-230.
49. [49] A. Sancar, Excision repair in mammalian cells, J. Biol. Chem. 270 (1995) 15915-15918.
50. [50] M.Z. Zdzienicka, Mammalian mutants defective in the response to ionizing radiation-induced DNA damage, Mutation Res. 336 (1995) 203-213.
51. [51] L.H. Thompson, Evidence that mammalian cells possess homologous recombinational repair pathways, Mutation Res. 363 (1996) 77-88.
52. [52] A.R. Lehmann, Molecular biology of DNA repair in the fission yeast Schizosaccharomyces pombe, Mutation Res. 363 (1996) 147-161.
53. [53] P.A. Jeggo, G.E. Taccioli, S.P. Jackson, Menage 'a trois: double strand break repair, V(D)J recombination and DNA-PK, Bioessays 17 (1995) 949-957.
54. [54] L. Grossman, Q. Wei, DNA repair capacity (DRC) as a biomarker of human variational responses to the environment, in: J.M. Vos (Ed.), DNA Repair Mechanisms: Impact on Human Diseases and Cancer, Landes Co., 1994, pp. 329-347.
55. [55] K.J. Helzlsouer, E.L. Harris, R. Parshad, S. Fogel, W.L. Bigbee, K.K. Sanford, Familial clustering of breast cancer: possible interaction between DNA repair proficiency and radiation exposure in the development of breast cancer, Int. J. Cancer 64 (1995) 14-17.
56. [56] M.R. Spitz, R.S. McPherson, H. Jiang, T.C. Hsu, Z. Trizna, J.J. Lee, S.M. Lippman, F.R. Khuri, L. Steffen-Batey, R.M. Chamberlain, S.P. Schantz, W.K. Hong, Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer, Cancer Epidemiol. Biomarkers Prev. 6 (1997) 687-692.
57. [57] R.D. Knight, R. Parshad, F.M. Price, R.E. Tarone, K.K. Sanford, X-ray-induced chromatid damage in relation to DNA repair and cancer incidence in family members, Int. J. Cancer 54 (1993) 589-593.
58. [58] X. Wu, J. Gu, T.C. Hsu, W.K. Hong, H. Shi, M.R. Spitz, Differential sensitivity to benzo(a]pyrene-diol-epoxide (BPDE) as a marker of lung cancer susceptibility, Proc. Am. Assoc. Cancer Res. 38 (1997) 618.
59. [59] S. Ray, B.J. Trock, J. Hanfelt, G.C. Roush, M. Berwick, J.J. Hu, DNA repair in human breast cancer: A molecular epidemiology study, Proc. Am. Assoc. Cancer Res. 38 (1997) 215.
60. [60] Q. Wei, L. Cheng, W.K. Hong, M.R. Spitz, Reduced DNA repair capacity in lung cancer patients, Cancer Res. 56 (1996) 4103-4107.
61. [61] M.R. Spitz, Risk factors and genetic susceptibility, in: W.K. Hong, R.S. Weber (Eds.), Head and Neck Cancer, Kluwer Academic Publishers, Hingham MA, USA, 1995, pp. 73-87.
62. [62] M.R. Spitz, T.C. Hsu, X. Wu, J.J. Fueger, C.I. Amos, J.A. Roth, Mutagen sensitivity as a biological marker of lung cancer risk in African Americans, Cancer Epidemiol. Biomarkers Prev. 4 (1995) 99-103.
63. [63] M.R. Spitz, T.C. Hsu, Mutagen sensitivity as a marker of cancer risk, Cancer Detect. Prev. 18 (1994) 299-303.
64. [64] K.J. Helzlsouer, E.L. Harris, R. Parshad, H.R. Perry, F.M. Price, K.K. Sanford, DNA repair proficiency: potential susceptibility factor for breast cancer, J. Natl. Cancer Inst. 88 (1996) 754-755.
65. [65] R. Parshad, F.M. Price, V.A. Bohr, K.H. Cowans, J.A. Zujewski, K.K. Sanford, Deficient DNA repair capacity, a predisposing factor in breast cancer, Br. J. Cancer 74 (1996) 1-5.
66. [66] D. Scott, A. Spreadborough, E. Levine, S.A. Roberts, Genetic predisposition in breast cancer, Lancet 344 (1994) 1444.
67. [67] E. Kovacs, A. Almendral, Reduced DNA repair synthesis in healthy women having first degree relatives with breast cancer, Eur. J. Cancer Clin. Oncol. 23 (1987) 1051-1057.
68. [68] N.B. Crompton, M. Ozsahin, A versatile and rapid assay of radiosensitivity of peripheral blood leukocytes based on DNA and surface-marker assessment of cytotoxicity, Radiat. Res. 147 (1997) 55-60.
69. [69] R.W. Pero, C. Bryngelsson, T. Bryngelsson, A. Norden, A genetic component of the variance of N-acetoxy-2-actylaminofluorene-induced DNA damage in mononuclear leukocytes determined by a twin study, Hum. Genet. 65 (1983) 181-184.
70. [70] R.W. Pero, D.B. Johnson, M. Markowitz, G. Doyle, M. Lund-Pero, J. Seidegard, M. Halper, D.G. Miller, DNA repair synthesis in individuals with and without a family history of cancer, Carcinogenesis 10 (1989) 693-697.
71. [71] M.R. Shen, I.M. Jones, H. Mohrenweiser, Non-conservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans, Cancer Res. 58 (1998) 604-608.
72. [72] R. Chakraborty, M.P. Little, K. Sankaranarayanan, Cancer predisposition, radiosensitivity and the risk of radiation-induced cancers: III. Effects of incomplete penetrance and dose-dependent radiosensitivity on cancer risks in populations, Radiat. Res. 147 (1997) 309-320.